89 a) Chez la femme non hystérectomisée b) Chez la femme hystérectomisée II.3) Les attitudes des remplaçants en matière, II.2.4) Connaissance des différents schémas, p.93 ,
98 II.3.6) Les réticences à la prescription de THM et les raisons, II.3.5) Les raisons, p.99 ,
104 V.1) Vision de la ménopause, p.104 ,
Vision, p.106 ,
URL : https://hal.archives-ouvertes.fr/hal-01220839
Relation entre la vision du THM des remplaçants de Gironde et leurs pratiques de prescription ou leurs attitudes, France (n= 77) Régression logistique en analyse univariable. REFERENCES 1. World Health Organisation. World Health Organisation. Research on the Menopause in the 1990's, EMC Endocrinol-Nutr, vol.10, pp.35-45, 2010. ,
Executive summary: stages of reproductive aging workshop (STRAW), Fertility and Sterility, vol.76, issue.5, pp.874-882, 2001. ,
DOI : 10.1016/S0015-0282(01)02909-0
Menopause: evidence-based practice, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.20, issue.6, pp.799-839, 2006. ,
DOI : 10.1016/j.bpobgyn.2006.07.001
Genetic influences on the age at menopause, The Lancet, vol.352, issue.9134, pp.1084-1089, 1998. ,
DOI : 10.1016/S0140-6736(05)79753-1
Alcohol, caffeine and smoking in relation to age at menopause, Maturitas, vol.54, issue.1, pp.27-38, 2006. ,
DOI : 10.1016/j.maturitas.2005.10.001
Le THM??: ??tat des connaissances en 2012, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.7, pp.1-2, 2012. ,
DOI : 10.1016/j.jgyn.2012.09.001
Epidémiologie de la population âgée en France, Real Gynecol Obstet, vol.114, pp.8-14, 2006. ,
Epidemiology of risk factors and symptoms associated with menopause in Spanish women, Maturitas, vol.62, issue.1, pp.30-36, 2009. ,
DOI : 10.1016/j.maturitas.2008.10.003
The European Menopause Survey 2005: Women's perceptions on the menopause and postmenopausal hormone therapy, Gynecological Endocrinology, vol.166, issue.7, pp.369-75, 2006. ,
DOI : 10.1016/j.fertnstert.2005.08.010
Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States, Climacteric, vol.80, issue.1, pp.32-43, 2008. ,
DOI : 10.1016/0378-5122(96)01046-8
Données en consultation pour la ménopause (problème et suivi) Available from : http ://omg.sfmg.org/content/ donnees/donnees.php 15 Risk factors for onset of menopausal symptoms : results from a large cohort study, Maturitas, vol.60, issue.2, pp.108-129, 2008. ,
A prospective population-based study of menopausal symptoms, Obstet Gynecol, vol.96, issue.3, pp.351-359, 2000. ,
Management of menopause-related symptoms Evidence report/technology assesment n°120. [Internet] Agency for Healthcare Research and Quality Available from : http ://archive.ahrq.gov, 2005. ,
Management of Menopausal Symptoms, New England Journal of Medicine, vol.355, issue.22, pp.2338-2385, 2006. ,
DOI : 10.1056/NEJMcp054015
A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century, Menopause, vol.9, issue.3, pp.156-61, 2002. ,
DOI : 10.1097/00042192-200205000-00003
Lifestyle and Demographic Factors in Relation to Vasomotor Symptoms: Baseline Results from the Study of Women's Health Across the Nation, American Journal of Epidemiology, vol.159, issue.12, pp.1189-99, 2004. ,
DOI : 10.1093/aje/kwh168
Differential diagnosis of hot flashes, Maturitas, vol.27, issue.3, pp.203-217, 1997. ,
DOI : 10.1016/S0378-5122(97)83974-6
Postmenopausal vaginal atrophy and atrophic vaginitis, Am J ,
DOI : 10.1016/s0002-9629(15)40205-8
Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones, JAMA: The Journal of the American Medical Association, vol.249, issue.16, pp.2195-2203, 1983. ,
DOI : 10.1001/jama.249.16.2195
Relation of Demographic and Lifestyle Factors to Symptoms in a Multi-Racial/Ethnic Population of Women 40-55 Years of Age, American Journal of Epidemiology, vol.152, issue.5, pp.463-73, 2000. ,
DOI : 10.1093/aje/152.5.463
Climacteric symptoms and sleep quality, Obstet Gynecol, vol.94, issue.2, pp.219-243, 1999. ,
Psychologic Distress and Natural Menopause: A Multiethnic Community Study, American Journal of Public Health, vol.91, issue.9, pp.1435-1477, 2001. ,
DOI : 10.2105/AJPH.91.9.1435
Estrogens and aging skin, Dermato-Endocrinology, vol.12, issue.2, pp.264-70, 2013. ,
DOI : 10.1016/j.freeradbiomed.2010.12.038
Development of the WHOQOL: Rationale and Current Status, International Journal of Mental Health, vol.1, issue.3, pp.24-56, 1994. ,
DOI : 10.1002/per.2410040304
Validation d'une méthode d'évaluation de la qualité de vie en ménopause, Réf Gyn Obst, vol.2, issue.2, pp.179-88, 1994. ,
M??nopause et os, Prévalence et caractéristiques de l'ostéoporose dans la population générale en France : l'étude Instant, pp.28-32, 2006. ,
DOI : 10.1016/j.jgyn.2012.09.005
Interrogation des données sur les causes de décès de, 1979. ,
Traitement hormonal de la ménopause et risque artériel, Rev Prat, vol.55, pp.383-391, 2005. ,
HRT and cardiovascular disease, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.23, issue.1, pp.109-129, 2009. ,
DOI : 10.1016/j.bpobgyn.2008.10.010
Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy, Current Opinion in Lipidology, vol.15, issue.4 ,
DOI : 10.1097/01.mol.0000137231.84772.80
M??nopause et risque cardiovasculaire, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.7, pp.13-22, 2012. ,
DOI : 10.1016/j.jgyn.2012.09.003
Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses, Neurology, vol.52, issue.1, pp.78-84, 1999. ,
DOI : 10.1212/WNL.52.1.78
Estrogen-containing hormone therapy and Alzheimer???s disease risk: Understanding discrepant inferences from observational and experimental research, Neuroscience, vol.138, issue.3 ,
DOI : 10.1016/j.neuroscience.2005.06.017
Is cognitive functioning detrimentally affected after early, induced menopause?, Menopause, vol.16, issue.1, pp.188-98, 2009. ,
DOI : 10.1097/gme.0b013e3181775eb4
La m??nopause comme ph??nom??ne culturel, Champ psy, vol.24, issue.4, pp.57-67, 2001. ,
DOI : 10.3917/cpsy.024.0057
Le deuxième sexe. Paris : Gallimard, 1949. ,
Feminine forever, 1966. ,
Beliefs about Menopause of General Practitioners and Mid-aged Women, Family Practice, vol.11, issue.4, pp.408-420, 1994. ,
DOI : 10.1093/fampra/11.4.408
"I should live and finish it": A qualitative inquiry into Turkish women's menopause experience, BMC Family Practice, vol.9, issue.4, 2009. ,
DOI : 10.3109/01674829809025694
The Menopause: Reward or Punishment?, Psychosomatics, vol.16, issue.4, pp.161-164, 1975. ,
DOI : 10.1016/S0033-3182(75)71183-0
The psychologie of feminine genital bleeding. An analysis of Mohave Indian puberty en menstrual rites, Int J Psychoanal, vol.31, pp.1-21, 1950. ,
Homicide and suicide among the Gisu, Princet Univ Press, pp.94-129, 1960. ,
Les représentations de la ménopause et les attitudes envers le traitement hormonal Une enquête de la population générale en France. in Epelboin S, Heritier-Auge F, Sureau C. Stéroïdes, ménopause et approche socio-culturelle, 1998. ,
A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study, Maturitas, vol.13, issue.1, pp.65-79, 1991. ,
DOI : 10.1016/0378-5122(91)90286-Y
Dossier de presse : 50 ans la vie devant soi, p.43, 2002. ,
Historique du traitement hormonal substitutif de la ménopause, Rev Prat, vol.55, pp.369-75, 2005. ,
The menopause industry : how the medical establishment exploites women. Hunter House, 1994. ,
Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens, New England Journal of Medicine, vol.293, issue.23, pp.1167-70, 1975. ,
DOI : 10.1056/NEJM197512042932303
Hormone replacement therapy and endometrial cancer risk: A meta-analysis, Obstetrics & Gynecology, vol.85, issue.2, pp.304-317, 1995. ,
DOI : 10.1016/0029-7844(94)00383-O
Menopause and the Risk of Coronary Heart Disease in Women, New England Journal of Medicine, vol.316, issue.18, pp.1105-1115, 1987. ,
DOI : 10.1056/NEJM198704303161801
Alzheimer's disease: A study of epidemiological aspects, Annals of Neurology, vol.118, issue.4, pp.335-376, 1984. ,
DOI : 10.1002/ana.410150406
A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer ,
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women, JAMA, vol.280, issue.7, pp.605-618, 1998. ,
DOI : 10.1001/jama.280.7.605
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy, JAMA, vol.288, issue.1, pp.49-57, 2002. ,
DOI : 10.1001/jama.288.1.49
Risks and benefits of Estrogen plus progestin in healthy postmenopausal women : Principal results from the Women's Health initiative randomized controlled trial, JAMA, vol.288, issue.3, pp.321-354, 2002. ,
Breast cancer and hormone-replacement therapy: the Million Women Study, The Lancet, vol.362, issue.9392 ,
DOI : 10.1016/S0140-6736(03)14590-4
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>, JAMA, vol.290, issue.13, pp.1729-1767, 2003. ,
DOI : 10.1001/jama.290.13.1729
Rapid Loss of Hip Fracture Protection After Estrogen Cessation: Evidence From the National Osteoporosis Risk Assessment, Obstetrics & Gynecology, vol.103, issue.3, pp.440-446, 2004. ,
DOI : 10.1097/01.AOG.0000114986.14806.37
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause, JAMA, vol.297, issue.13, pp.1465-77, 2007. ,
DOI : 10.1001/jama.297.13.1465
Brief report : Coronary heart disease events associated with hormone therapy in younger and older women ,
Press Release-Hormone therapy has many favorable effects in newly menopausal women : Initial findings of the Kronos Early Estrogen Prevention Study (KEEPS) [Internet]. 2012 Available from : http ://www.menopause. org/docs/agm/general-release.pdf?sfvrsn=0 76 Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women : randomised trial, Trial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal women, p.8141, 2012. ,
Study had insufficient power to investigate safety, BMJ, vol.345, issue.dec03 2, p.8146, 2012. ,
DOI : 10.1136/bmj.e8146
Hormone therapy for preventing cardiovascular disease in post-menopausal women Association between hormone replacement therapy and subsequent stroke : a meta-analysis, Cochrane Database Syst Rev. Commentary. BMJ, vol.4330, issue.7487, pp.342-347, 2005. ,
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women, JAMA, vol.289, issue.20, pp.2673-84, 2003. ,
DOI : 10.1001/jama.289.20.2673
Reprod hum horm, pp.241-246, 2003. ,
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. The Lancet, pp.428-460, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-01026273
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis, BMJ, vol.336, issue.7655, pp.1227-1258, 2008. ,
DOI : 10.1136/bmj.39555.441944.BE
URL : https://hal.archives-ouvertes.fr/inserm-01142884
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/hal-00688234
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, JAMA, vol.289, issue.24, pp.3243-53, 2003. ,
DOI : 10.1001/jama.289.24.3243
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study, Breast Cancer Research and Treatment, vol.95, issue.1, pp.103-114, 2008. ,
DOI : 10.1007/s10549-007-9523-x
URL : https://hal.archives-ouvertes.fr/inserm-00201813
Risk of Breast Cancer by Type of Menopausal Hormone Therapy : a Case-Control Study among Post-Menopausal Women in France Available from : http ://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815310/ 92. Fournier A, Mesrine S, Boutron-Ruault M-C, Clavel-Chapelon F. Estrogen-progestagen menopausal hormone therapy and breast cancer : does delay from menopause onset to treatment initiation influence risks, PLoS ONE [Internet]. J Clin Oncol Off J Am Soc Clin Oncol, vol.827, issue.1131, pp.5138-5181, 2009. ,
Decline in breast cancer incidence in France : a paradoxical trend, Bull Cancer, vol.95, issue.1, pp.11-16, 2005. ,
Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?Rev épi Santé Pub, pp.297-301, 2008. ,
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis, The American Journal of Medicine, vol.106, issue.5, pp.574-82, 1999. ,
DOI : 10.1016/S0002-9343(99)00063-7
Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.5, pp.1531-1538, 2009. ,
DOI : 10.1158/1055-9965.EPI-08-1209
M??nopause et risques carcinologiques, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.7, pp.33-40, 2012. ,
DOI : 10.1016/j.jgyn.2012.09.006
Endometrial cancer and hormone-replacement therapy in the Million Women Study, Lancet, vol.365, issue.9470, pp.1543-51, 2005. ,
Risks of Endometrial Cancer Associated With Different Hormone Replacement Therapies in the E3N Cohort, 1992-2008, American Journal of Epidemiology, vol.180, issue.5, pp.508-525, 1992. ,
DOI : 10.1093/aje/kwu146
Ovarian cancer and hormone replacement therapy in the Million Women Study, The Lancet, vol.369, issue.9574, pp.1703-1713, 2007. ,
DOI : 10.1016/S0140-6736(07)60534-0
Ovarian cancer and hormone replacement therapy. The Lancet, p.932, 2007. ,
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial, The Lancet, vol.374, issue.9697, pp.1243-51, 2009. ,
DOI : 10.1016/S0140-6736(09)61526-9
Estrogen and Cognitive Functioning in Women, Endocrine Reviews, vol.24, issue.2, pp.133-51, 2003. ,
DOI : 10.1210/er.2001-0016
Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women<SUBTITLE>Women's Health Initiative Memory Study</SUBTITLE>, JAMA, vol.291, issue.24, pp.2959-68, 2004. ,
DOI : 10.1001/jama.291.24.2959
Hormone replacement therapy for cognitive function in postmenopausal women, Cochrane Database Syst Rev, vol.356, issue.2, p.3122, 2008. ,
DOI : 10.1002/14651858.CD003122.pub2
Mortality associated with hormone replacement therapy in younger and older women, Journal of General Internal Medicine, vol.25, issue.7, pp.791-804, 2004. ,
DOI : 10.1111/j.1525-1497.2004.30281.x
Qualité de vie de 214 femmes ménopausées en fonction de la prise ou non de THS, Rev Prat Méd Gén, vol.18673, issue.672, pp.1431-1436, 2004. ,
Global Consensus Statement on menopausal hormone therapy, Maturitas, vol.74, issue.4, pp.391-393, 2013. ,
DOI : 10.1016/j.maturitas.2013.02.001
Où en est-on après 5 ans de réduction des prescriptions du THM? Rev Prat, pp.1118-1139, 2010. ,
Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts, Menopause, vol.18, issue.2, pp.219-242, 2011. ,
DOI : 10.1097/gme.0b013e3181ecf3ec
Réévaluation des traitements hormonaux de la ménopause ,
Le traitement hormonal de la ménopause(THM) Point d'étape ,
Traitement hormonal de la ménopause et cancers du sein (suite) Revue Prescrire, p.909, 2008. ,
Troubles liés à la ménopause : traitement symptomatique. Idées-Forces Prescrire . Revue Prescrire Available from : http ://www.prescrire.org/Fr/ IFPList.aspx 117. Prescrire. Prévenir les fractures après la ménopause. Revue Prescrire, 2014. ,
Promestriene , a specific topic estrogen. Review of 40 years of vaginal atrophy treatment : is it safe even in cancer patients? Anticancer Drugs, pp.989-98, 2013. ,
Perspective on hormone therapy 10 years after the WHI, Maturitas, vol.76, issue.3, pp.208-220, 2013. ,
DOI : 10.1016/j.maturitas.2013.08.014
Short and long term effects of tibolone in postmenopausal women, Cochrane Database Syst Rev, vol.273, issue.4, p.8536, 2012. ,
DOI : 10.1002/14651858.CD008536.pub2
Complementary and Alternative Therapies for the Management of Menopause-Related Symptoms, Archives of Internal Medicine, vol.166, issue.14, pp.1453-65, 2006. ,
DOI : 10.1001/archinte.166.14.1453
Alternative treatments for the menopause, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.23, issue.1, pp.151-61, 2009. ,
DOI : 10.1016/j.bpobgyn.2008.10.006
Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial, Fertility and Sterility, vol.68, issue.6, pp.981-987, 1997. ,
DOI : 10.1016/S0015-0282(97)00397-X
Drug-herb interactions with herbal medicines for menopause, Menopause International, vol.10, issue.4, pp.162-167, 2004. ,
DOI : 10.1258/1362180042721067
Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women : a double-blind, placébo-controlled trial ,
Panax ginseng, Drug Safety, vol.264, issue.6122, pp.323-367, 2002. ,
DOI : 10.2165/00002018-200225050-00003
Treating hot flushes in menopausal women with homeopathic treatment???Results of an observational study, Homeopathy, vol.97, issue.1, pp.10-15, 2008. ,
DOI : 10.1016/j.homp.2007.11.005
Homeopathy for Menopausal Symptoms in Breast Cancer Survivors: A Preliminary Randomized Controlled Trial, The Journal of Alternative and Complementary Medicine, vol.11, issue.1, pp.21-28, 2005. ,
DOI : 10.1089/acm.2005.11.21
A Pilot, Randomized, Double-Blinded, Placebo-Controlled Trial of Individualized Homeopathy for Symptoms of Estrogen Withdrawal in Breast-Cancer Survivors, The Journal of Alternative and Complementary Medicine, vol.11, issue.1, pp.13-20, 2005. ,
DOI : 10.1089/acm.2005.11.13
The Benefits and Harms of Systemic Dehydroepiandrosterone (DHEA) in Postmenopausal Women With Normal Adrenal Function: A Systematic Review and Meta-analysis, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.10, pp.3536-3578, 2014. ,
DOI : 10.1210/jc.2014-2261
Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study, Annals of Internal Medicine, vol.132, issue.10, pp.788-93, 2000. ,
DOI : 10.7326/0003-4819-132-10-200005160-00004
Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study, Menopause, vol.12, issue.1, pp.18-26, 2005. ,
DOI : 10.1097/00042192-200512010-00006
Use of Antidepressants and Rates of Hip Bone Loss in Older Women, Archives of Internal Medicine, vol.167, issue.12, pp.1240-1245, 2007. ,
DOI : 10.1001/archinte.167.12.1240
pourquoi il est déconseillé de les associer-point d'information [Internet] Available from : http ://www.ansm.sante. fr/S-informer/Points-d-information-Points-d-information/Tamoxifene-et-fluoxetine- ou-paroxetine-pourquoi-il-est-deconseille-de-les-associer-Point-d-information, 2010. ,
Management of Postmenopausal Hot Flushes With Venlafaxine Hydrochloride: A Randomized, Controlled Trial, Obstetrics & Gynecology, vol.105, issue.1, pp.161-167, 2005. ,
DOI : 10.1097/01.AOG.0000147840.06947.46
Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial, Obstetrics & Gynecology, vol.101, issue.2, pp.337-382, 2003. ,
DOI : 10.1016/S0029-7844(02)02712-6
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women, JAMA, vol.281, issue.23, pp.2189-97, 1999. ,
DOI : 10.1001/jama.281.23.2189
Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model, Climacteric, vol.18, issue.1, pp.618-646, 2013. ,
DOI : 10.1097/gme.0b013e318212499c
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>, JAMA, vol.282, issue.7, pp.637-682, 1999. ,
DOI : 10.1001/jama.282.7.637
Effects of Raloxifene on Fracture Risk in Postmenopausal Women: The Raloxifene Use for The Heart Trial, Journal of Bone and Mineral Research, vol.11, issue.S1, pp.112-132, 2008. ,
DOI : 10.1359/jbmr.070904
L'activit?? gyn??cologique des m??decins g??n??ralistes en Bretagne, Sant?? Publique, vol.17, issue.1, pp.109-128, 2005. ,
DOI : 10.3917/spub.051.0109
Dépistage des cancers : et si on pensait au généraliste? Panor Méd, pp.26-31, 1999. ,
Impact de??l'??tude WHI sur??le??comportement des??femmes m??decins vis-??-vis de??la??m??nopause, Gyn??cologie Obst??trique & Fertilit??, vol.34, issue.6, pp.499-505, 2006. ,
DOI : 10.1016/j.gyobfe.2006.03.024
La prescription de traitement hormonal substitutif de la ménopause dans le Nord-Pas-De-Calais : quels changements depuis 2002, Méd Reprod, vol.8, issue.1, pp.61-66, 2006. ,
Traitement hormonal de la ménopause (THM) : le point chez les médecins généralistes des Bouches-du-Rhône, 2010. ,
105 médecins généralistes de la Haute-Garonne et leurs patientes face à la ménopause depuis les recommandations de, 2004. ,
Mission de concertation sur la médecine de proximité ,
Generalized Raking Procedures in Survey Sampling, Journal of the American Statistical Association, vol.13, issue.423 ,
DOI : 10.1080/01621459.1990.10474969
Swedish gynecologists' and general practitioners' views on the climacteric period, Knowledge, attitudes and management strategies, Acta Obstetricia et Gynecologica Scandinavica, vol.77, issue.9, pp.909-925, 1998. ,
DOI : 10.1080/j.1600-0412.1998.770907.x
Hormone replacement therapy : a survey of Ontario physicians' prescribing practices, CMAJ, vol.161, issue.6, pp.695-703, 1999. ,
Current trends in hormone replacement therapy: perceptions and usage, Climacteric, vol.11, issue.3, pp.192-200, 2008. ,
DOI : 10.1016/S0140-6736(05)65943-0
The general practitioner's view on hormone replacement therapy during and after menopause. Tidsskr Den Nor Laegeforen Tidsskr Prakt Med Ny Raekke, pp.1500-1503, 2007. ,
Enquête autour de la ménopause et du traitement hormonal de la ménopause chez les médecins généralistes des Côtes-d'Armor en 2013, Thèse de Médecine générale, pp.2014-2040 ,
Le point de vue des médecins généralistes du Laonnois sur le traitement hormonal substitutif de la ménopause, Amiens, vol.110, p.2014 ,
Personal use of hormone therapy by postmenopausal women doctors and male doctors??? wives in Italy after the publication of WHI trial, Maturitas, vol.54, issue.2, pp.181-92, 2006. ,
DOI : 10.1016/j.maturitas.2005.10.008
mal-être physique ? Un mal-être psychique ? Un soulagement ? La fin de la sexualité ? La fin de la vie de femme, de la féminité ? Un changement physique hormonal sans autre retentissement ? Une nouvelle étape dans la vie d'une femme ? ,
Un moyen de préserver une qualité de vie ? Un moyen de préserver une sexualité ? Un moyen de préserver la féminité ? Un moyen de d' éviter l' ostéoporose ? Un moyen d' éviter les fractures ? Un traitement indiqué chez certaines femmes et sous certaines conditions ? La médicalisation d'un phénomène physiologique normal ? ,
Je ne sais pas ? Qui êtes vous? 26) Vous êtes? (Veuillez sélectionner une seule des propositions suivantes ,